CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 38 enrolled
Drug / intervention
Transcranial Photobiomodulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04569058
NCT04569058N/ACompleted
CompareCT.gov

Transcranial Photobiomodulation Therapy for the Treatment of Autistic Traits in Children and Adolescents With Attention Deficit Hyperactivity Disorder

Massachusetts General Hospital·interventional·Posted Sep 29, 2020·Updated Dec 8, 2025

In Brief

A clinical study evaluating Transcranial Photobiomodulation for Autism and Attention Deficit Hyperactivity Disorder. Completed, enrolled 38 participants across 1 site.

Detailed Summary

An open label trial to assess the safety and efficacy of transcranial photobiomodulation (tPBM) in improving autistic traits in ADHD youth.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAutism, Attention Deficit Hyperactivity Disorder
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedSep 29, 2020
Enrollment StartJan 14, 2021
Primary CompletionOct 31, 2024
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 5.8 years ago

Interventions

Transcranial Photobiomodulationdevice

Transcranial Photobiomodulation--a noninvasive intervention in which near-infrared light (850 nanometer) is applied to forebrain.